{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-24-012201","form_type":"8-K","ticker":"PGEN","cik":"0001356090","company_name":"PRECIGEN, INC.","filed_at":"2024-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.768824+00:00","generated_at":"2026-05-31T09:16:33.629446+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Precigen Q2 net loss widens to $58.8M; pivots to PRGN-2012 with BLA submission planned H2 2024","bullets":["Q2 2024 net loss of $58.8M ($0.23/share) vs $20.3M loss a year ago; includes impairment charge of $32.9M.","Total revenues fell 59% YoY to approx $0.8M; R&D expenses rose 32% on severance and PRGN-2012 trial costs.","Strategic reprioritization focuses on PRGN-2012 BLA submission under accelerated path H2 2024; workforce reduced >20%.","Appointed Phil Tennant as CCO for potential PRGN-2012 commercial launch; raised $31.4M net in August public offering.","Cash runway expected into early 2025; ActoBio subsidiary shut down, IP portfolio available for sale."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-24-012201","json":"https://secwatch.observer/filing/0000950103-24-012201.json","markdown":"https://secwatch.observer/filing/0000950103-24-012201.md","text":"https://secwatch.observer/filing/0000950103-24-012201.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356090/000095010324012201/0000950103-24-012201-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356090/000095010324012201/dp216654_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:16:33.629446+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}